Feasibility of autologous stem cell transplantation in chronic carriers of hepatitis B and hepatitis C virus

Leukemia and Lymphoma

Volumn 36, Issue 3-4, 2000, Pages 323-330

  Sperotto, Alessandra ^a,b   Silvestri, Federico ^b   Fanin, Renato ^b   Damiani, Daniela ^b   Geromin, Antonella ^b   Cerno, Michela ^b   Stocchi, Raffaella ^b   Patriarca, Francesca ^b   Baccarani, Michele ^b  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

^b Division of Haematology   (Italy)

Author keywords

Autologous stem cell transplantation; Chronic HCV and HBV infections

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOGRAFT; BREAST CANCER; CANCER SURVIVAL; CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DISEASE CARRIER; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TOXICITY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION;

EID: 0033957614     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190009148853     Document Type: Article

References (36)

1. Lau, JYN., Lai, L.C., Lin, H.J., Lok A.S.F., Liang R.H.S., Wu P.C., Chan T.K. and Todd, D. (1989) Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med, 36, 47-54.
2. Locasciulli, A., Bacigulupo, A., Van Lint, M.T., et al. (1990) Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transplant, 6, 25-29.
3. Reed, E.C., Myerson, D., Corey, L., and Meyers, J.D. (1991) Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen. Blood 77, 195-200.
4. Thung, S.N., Gerber MA, Klion F. et al. (1985) Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier. Arch Intern Med, 145: 1313-1314.
5. Pariente, E.A., Goudeau, A., Dubois, F., Degott C., Gluckman, E., Devergie, A., Brechot, C., Schenmetzler, C., and Bernuau, J. (1988) Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci. 33:1185-1191.
6. Bird, G.L.A., Smith, H., Portmann, B., Alexander, G.J.M., and Williams, R. (1989) Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med, 73: 895-902.
7. Cavanna, L., Sballi, G., Tanzi, E., Romano, L., Civardi, G., Buscarini, E., Vallisa, D., Bertè, R., and Rossi, A. (1995). High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. Haematologica, 89: 486-487;.
8. Ferri, C., Caracciolo, F., Zignego, A.L., La Civita, L., Monti, M., Longobardo, G., Lombardini, F., Greco, F., Capochiani, E., Mazzoni, A., Mazzaro, C., and Pasero, G. (1994). Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 88: 392-394.
9. Bellentani S, Tiribelli C, Saccoccio G. et al. (1944) Prevalence of chronic liver disease in the general population of northen Italy: the Dionysos Study. Hepatology, 20: 1442-1449.
10. Silvestri, F., Pipan, C., Barillari, G., Zaja, F., Fanin, F., Infanti, L., Russo, D., Falasca, E., Botta, A.G., and Baccarani, M. (1996) Prevalence of hepatitis C virus infection in patients with lymphproliferative disorders. Blood, 10: 4296-4301.
11. Infanti, L., Silvestri, F., Fanin, R., et al. (1996) The F-MACHOP regimen in the treatment of aggressive non-Hodgkin's lymphomas: a single centre experience in 72 patients. Heamatologica, 81: 521-528.
12. Lau, G.K.K., Liang, R., Chiu, E.K.W., Lee, C.K., and Lam, S.,K. (1997) Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study. Bone Marrow Transplant. 19: 795-799.
13. Silvestri, F., Fanin, R., Sperotto, A., Geromin, A., Cerno, M. Infanti, L., Stocchi, R., Damiani, D. and Baccarani, M. (1998) Lamivudine for the prevention of hepatitis B virus (HBV) reactivation during autologous stem cell (SC) transplantation: a case report. Blood, 92: 338b (abstract).
14. Galbraith, R.M., Eddleston, A.L.W.F., Williams, R. (1975). Fulminant hepatic failure in leukaemia and chriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet, 2: 528-530.
15. Wands, J.R. (1975) Subacute and chronic active hepatitis after withdrawal of chemotherapy (abstr). Lancet, 2: 979.
16. Hanson, C.A., Sutherland, D.E., Snover, D.C., et al. (1985) Fulminant hepatic failure in an HBsAg carrier renal transplant patient following cessation of immunosuppressive therapy. Transplantation, 39: 311-312.
17. Scullard, G.H., Smith, C.I., Meringan, T.C., Robinson, W.S., and Gregory P.B. (1981) Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology, 81: 987-991.
18. Hoofnagle, J.H., Dusheiko, G.M., Schafer, D.F., et al. (1982) Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med, 96: 447-449.
19. Rakela, J., Redeker, A.G., Weliky, B. (1983) Effect of short-term prednisone therapy on amino transferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology, 84: 956-960.
20. Brechot, G., Pourcel, C., Hadchouel, M., et al. 1982) State of hepatitis B virus DNA in liver disease. Hepatology, 2: 279-345.
21. Lefkowitch, J.H., Schiff, E.R., Davis, G.L., et al. (1993) Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology. 104: 595-603.
22. Dienes, H.P., Popper, H., Arnold, W., et al. (1982) Histology observations in human hepatitis non-A, non-B. Hepatology, 2: 562-571.
23. Mondelli, M., Alberti, A., Tremolada, F. et al. (1986) In vitro cell-mediated cytotoxicity for autologous liver cell in chronic non-A, non-B hepatitis. Clin Exp Immunol, 63: 147-155.
24. Fong, T.S., Valinluck, B., Govindarajan, S., Charboneau, F., Adkins, R.H., and Redeker, A.G. (1994) Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology, 107: 196-199.
25. Editorial. (1989) Chemotherapy and hepatitis B. Lancet, 2: 1130-1137.
26. Villa, E., Theodossi, A., Portmann, B., et al. (1981) Reactivation of hepatitis B virus infection in two patients: immunofluorescence studies of liver tissue. Gastroenterology, 80: 1048-1050.
27. Lok, A.S.F., Liang, R.H.S., Chiu, E.K.W., Wong, K.L., Chan, T.K., and Todd, D. (1991) Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology, 100: 182-188.
28. Davis, G.L., Hoofnagle, J.H. (1991) Reactivation of chronic hepatitis B virus infection. Gastroenterology, 92: 2028-2030.
29. Dienstag, J.L., Perrillo, R.P., Schiff, E.R., Bartholomew, M., Vicary, C., and Rubin, M. (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. New Engl J Med, 333: 1657-1661.
30. Schalm, S.W., de Man, R.A., Heijtink, R.A., et al. (1995) New nucleoside analogues for chronic hepatitis B. J Hepatol, 22: 52-56.
31. Boker, K.H.W., Ringe, B., Kruger, M., et al. (1994) Prostaglandin E plus famciclovir-a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation, 57: 1706-1708.
32. Tur-kaspa, R., Burk, R.D., Shaul, Y., et al. (1986) Hepatitis B virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA, 83: 1627-1631.
33. Chou, C.K., Wang, L.H., Lin, H.M., et al. (1992) Glucocorticoid stimulates hepalitis B viral gene expression in cultured human hepatoma cells. Hepatology, 16: 13-18.
34. Ohtsu T, Sai T, Oka M, Sugai, Y., and Tobinai, K. (1991) Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with haematological malignancies. Jpn J Clin Oncol, 21: 360-365.
35. Magrin, S., Craxi, A., Fabiano, C., Simonetti, G., Florentino, G., Marino, L., Diquattro, O., Di Marco, V., Liacono, O., Volpes, R., Almasio, P., Urdea, S.M., Neuwald, P., Pescador, S.R., Detmer, J., Wilber, J.C., and Pagliaro, L. (1994) Hepatitis C viremia in chronic liver disease: relationship to Interferon-alfa or corticosteroid treatment. Hepatology, 19: 274-279.
36. Chen, P.M., Fan, S., Liu, C.J., Hsieh, R.K. Hwang, J., Chuang, W., Liu, R.S.R., and Hwa, C. (1995) Changing of hepatitis B virus markers in patients treated with bone marrow transplantation. Transplantation, 49: 708-713.